Pure Global

AMH - India CDSCO Medical Device Registration

AMH is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000365_ef72c09bacb6663782384c46c149c0aa_d0a382c75ea577807c4c206de7e97abd. This device is marketed under the brand name AFIAS Infliximab . The license holder is BODITECH MED INDIA PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
AMH
UID: IMP/IVD/2021/000365_ef72c09bacb6663782384c46c149c0aa_d0a382c75ea577807c4c206de7e97abd

Brand Name

AFIAS Infliximab

Device Class

Class B

Approving Authority

CDSCO

Product Information

AFIAS AMH is a fluorescence Immunoassay (AFIAS Infliximab ) for the quantitative determination of AMH (AFIAS Infliximab ) in human serum/plasma. It is useful as an aid in management and monitoring of premature ovarian insufficiency, menopause, and ovarian reserve

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing